🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This reads like a somewhat harsh manuscript review.

National Lipid Association Marlys Koschinsky Maya S Safarova, MD, PhD Lipoprotein(a) is proinflammatory, proatherogenic, and prothrombotic. Approximately 20% of the global population has elevated Lp(a).

Yes! Yes! Yes!

National Lipid Association Yes! But important to note that distribution of Lp(a) levels varies in different groups. A higher proportion of Black and South Asian groups have elevated Lp(a) compared to Caucasians. #measureLpa

NYT: “But while there were plenty of flash points, there did not seem to be a knockout blow that could fundamentally alter the dynamics of what by all measures will be an exceedingly close election in November.” If you ignore the many times Trump punched himself out…

Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System, JCL in press. kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

Found out today that my hidden curriculum work was featured in the Academica Top 10! I am still so proud of this project and am grateful to everyone who contributed to the work. Let’s keep pushing to teach students important skills. academica.ca/top-ten/wester…

#CLVS first evening started with a bang, with a tour-de-force presentation by Julia St John (Assini) on her very exciting Lp(a) transgenic mouse work!

Simon Ofiara makes his conference debut at #CLVS2024. Very intriguing work in Lp(a) biosynthesis!

The more we learn about Lp(a) the more we have to worry about the 1 out of 5 people who have elevations. Will significantly lowering Lp(a) solve the aortic valve deterioration? For those of you with elevated Lp(a) make sure your clinicians are closely watching the heart valves.

#BeautifulCover

Dr Dean Karalis and Dan Soffer kicking off the Cardiovascular Institute of Philadelphia program on Lp(a) with Marlys Koschinsky! Excited to represent Family Heart Foundation at this important program! Leading cause of death in Philly? Heart disease!

#KnowLpa Superb presentation by Marlys Koschinsky on Lp(a) at the Cardiovascular Institute of Philadelphia event! ➡️ 6x more atherogenic than LDL ➡️ 20% of the population has high Lp(a); 30% of people of African descent ➡️ Pro-thrombotic ➡️ New therapies coming from Novartis, Amgen 🧪🔬🧬, Eli Lilly and Company Family Heart Foundation

Social media is that special place where you can find someone trying to explain The Handmaid’s Tale to the author of The Handmaid’s Tale.

This study contributes to understanding the effects of PCSK9 inhibitor administration on plaque composition 🔗atherosclerosis-journal.com/article/S0021-… #Evolocumab #PCS9i #CvPrev European Atherosclerosis Society Elsevier Cardiology

Core metabolic pathways Source & PDF Download Bibel, B., & The bumbling biochemist. (2024). Core Metabolic Roadmap. Zenodo. zenodo.org/records/133697…